ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Editorial

Editorial

Allan Tasman, MD

I hope you'll take a little time to read The Lancet Psychiatry Commission on the Future of Psychiatry, and to reflect on how we’ll address a number of issues critically important to the future of our profession.

Allan Tasman, MD

Like all things in our technologically advanced society, for all hard-working, empathy-challenged doctors comes a new and easy, although not painless, way to gain empathic ability...an empathy gadget?

©TITHI LUADTHONG/SHUTTERSTOCK.COM

Here's how I've managed to get my own mind off the news. What about you?

Dr. Brian Miller

Brian Miller joins the Editorial Board of Psychiatric Times.

Michelle Riba, MD, MS

We psychiatrists can't solve the world's political problems, but we can help those who are affected by them. Suggestions here.

© ALEXILUSMEDICAL /SHUTTERSTOCK.COM

We’ve been waiting since 1953, the year chlorpromazine was introduced to the US as a revolutionary treatment for schizophrenia, for an active treatment for tardive dyskinesia that the FDA judged to be effective.

At Psychiatric Times, it has long been our goal to publish cutting-edge information from the frontiers of psychiatry. In this this spirit, we welcome Dr. Thomas G. Schulze, one of the world’s leading experts on psychiatric genetics to our Editorial Board.

Pages

Subscribe to Editorial on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.